Get the Stockscreener App
5.93
1.33%
-0.08
Generation Bio Co stock is traded at $5.93, with a volume of 68,564.
It is down -1.33% in the last 24 hours and up +46.42% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$6.01
Open:
$5.97
24h Volume:
68,564
Relative Volume:
0.21
Market Cap:
$39.94M
Revenue:
$21.23M
Net Income/Loss:
$-72.42M
P/E Ratio:
-0.8759
EPS:
-6.77
Net Cash Flow:
$-81.69M
1W Performance:
-1.00%
1M Performance:
+46.42%
6M Performance:
+12.95%
1Y Performance:
-76.56%
1-Day Range:
$5.61
$6.00
1-Week Range:
$5.61
$6.25
52-Week Range:
$3.004
$29.10
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
5.93 | 40.28M | 21.23M | -72.42M | -81.69M | -6.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Risk adjusted return profile for Generation Bio Co. analyzed2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Using economic indicators to assess Generation Bio Co. potentialMarket Rally & Smart Investment Allocation Tips - Newser
How to track smart money flows in Generation Bio Co.2025 EndofYear Setup & AI Driven Stock Movement Reports - Newser
Combining price and volume data for Generation Bio Co.Trade Analysis Report & Fast Momentum Entry Tips - Newser
Is now a turning point for Generation Bio Co.Risk Management & Technical Pattern Alert System - Newser
Top chart patterns to watch in Generation Bio Co.Take Profit & Growth Focused Stock Pick Reports - Newser
Chart based exit strategy for Generation Bio Co.July 2025 Final Week & Real-Time Stock Price Movement Reports - Newser
Backtesting results for Generation Bio Co. trading strategiesWeekly Stock Recap & AI Driven Price Predictions - Newser
Visualizing Generation Bio Co. stock with heatmapsGap Down & High Yield Equity Trading Tips - Newser
Real time scanner hits for Generation Bio Co. explained2025 Market Sentiment & Daily Market Momentum Tracking - Newser
Analyzing Generation Bio Co. with risk reward ratio chartsSwing Trade & Expert Curated Trade Setups - Newser
What data driven models say about Generation Bio Co.’s futureMarket Volume Summary & High Conviction Buy Zone Picks - Newser
Live market analysis of Generation Bio Co.Earnings Miss & Consistent Growth Stock Picks - Newser
Generation Bio Co. stock chart pattern explainedBear Alert & Low Drawdown Momentum Trade Ideas - Newser
Can machine learning forecast Generation Bio Co. recoveryWeekly Investment Report & Free Growth Oriented Trading Recommendations - Newser
Can trapped investors hope for a rebound in Generation Bio Co.Market Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
Should you wait for a breakout in Generation Bio Co.2025 Earnings Impact & Reliable Breakout Stock Forecasts - Newser
What earnings revisions data tells us about Generation Bio Co.July 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
Measuring Generation Bio Co.’s beta against major indicesMarket Growth Summary & Stock Portfolio Risk Control - Newser
Generation Bio Co. stock prediction for this weekJuly 2025 Breakouts & Reliable Trade Execution Plans - Newser
Can technical indicators confirm Generation Bio Co.’s reversalDip Buying & Low Drawdown Trading Techniques - Newser
Analyzing drawdowns of Generation Bio Co. with statistical toolsWeekly Investment Recap & Technical Analysis for Trade Confirmation - Newser
Is Generation Bio Co. a defensive stockWeekly Gains Summary & Reliable Entry Point Alerts - Lancaster City Council
Growth Value: Will Generation Bio Co. stock hit new highs in YEARJuly 2025 Rallies & Low Risk Growth Stock Ideas - Lancaster City Council
Published on: 2025-09-09 00:12:15 - beatles.ru
Has Generation Bio Co. found a price floorEarnings Overview Report & Community Consensus Stock Picks - Newser
Visual trend scoring systems applied to Generation Bio Co.Portfolio Gains Report & Verified High Yield Trade Plans - Newser
Traders Watching For Reversal Pattern in Generation Bio Co.July 2025 Recap & Trade Opportunity Analysis - beatles.ru
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Generation Bio Co Stock (GBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
| Howze Yalonda | CHIEF LEGAL OFFICER |
Oct 15 '24 |
Option Exercise |
2.42 |
3,347 |
8,100 |
15,169 |
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):